|
|
Breast Cancer
Treatment and Research - Latest Research
The Study of Tamoxifen and Raloxifene (STAR) is a more recent
clinical trial sponsored by the National Cancer Institute. STAR
enlisted nearly 20,000 women to compare tamoxifen to the drug
raloxifene for effectiveness in reducing of breast cancer risk.
|
| |
|
|
|
